vaginosis

Secnidazole (PM-185184) is a second-generation 5-nitroimidazole antimicrobial that is structurally related to other 5-nitroimidazoles including [DB00916] and [DB00911], but displays improved oral absorption and longer terminal elimination half-life than antimicrobial agents in this class [A27210]. Secnidazole is selective against many anaerobic Gram-positive and Gram-negative bacteria and protozoa.

Clindamycin Phosphate is the phosphate salt form of clindamycin, a semi-synthetic, chlorinated broad-spectrum antibiotic produced by chemical modification of lincomycin. Clindamycin phosphate (Clindamycin 2-dihydrogen phosphate) is used in topical preparations.

Clindamycin phosphate hydrochloride (Clindamycin 2-phosphate), a broad-spectrum bacteriostatic lincosamide antibiotic, serves as a prodrug of Clindamycin. It lacks antimicrobial activity in vitro; however, through phosphatase ester hydrolysis, it is rapidly converted to the active form, Clindamycin, in vivo. This compound is utilized in the research of acne and bacterial vaginosis [1] [2] [3].